NU Skin Enterprises Inc
NYSE:NUS

Watchlist Manager
NU Skin Enterprises Inc Logo
NU Skin Enterprises Inc
NYSE:NUS
Watchlist
Price: 5.77 USD 0.87% Market Closed
Market Cap: 285.1m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one NUS stock under the Base Case scenario is 21.89 USD. Compared to the current market price of 5.77 USD, NU Skin Enterprises Inc is Undervalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NUS Relative Value
Base Case
21.89 USD
Undervaluation 74%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
98
vs Industry
86
Median 3Y
0.5
Median 5Y
0.7
Industry
1
Forward
0.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
5
Median 3Y
15.8
Median 5Y
13.5
Industry
16.4
Forward
5.8
More Details
2.6
P/OCF
P/OCF
Price to OCF
2.6
vs History
95
vs Industry
62
Median 3Y
9.4
Median 5Y
7.9
Industry
11.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
51
Median 3Y
11.4
Median 5Y
11.4
Industry
17.6
More Details
0.4
P/B
P/B
Price to Book Value
0.4
vs History
98
vs Industry
73
Median 3Y
1.2
Median 5Y
2
Industry
1.5
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
96
vs Industry
81
Median 3Y
0.6
Median 5Y
0.7
Industry
1.1
Forward
0.3
More Details
0.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.4
vs History
96
vs Industry
87
Median 3Y
0.9
Median 5Y
1
Industry
3.7
More Details
3.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.8
vs History
90
vs Industry
58
Median 3Y
6.8
Median 5Y
6.3
Industry
9.6
Forward
2.4
More Details
8.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8.9
vs History
60
vs Industry
39
Median 3Y
11
Median 5Y
9.7
Industry
12.5
Forward
4.6
More Details
4.1
EV/OCF
EV/OCF
Enterprise Value to OCF
4.1
vs History
90
vs Industry
57
Median 3Y
9.7
Median 5Y
9
Industry
11.9
More Details
6.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
6.5
vs History
90
vs Industry
42
Median 3Y
14.4
Median 5Y
13.3
Industry
15.1
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
96
vs Industry
74
Median 3Y
0.8
Median 5Y
1.2
Industry
1.2
More Details

Multiples Across Competitors

NUS Competitors Multiples
NU Skin Enterprises Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
NU Skin Enterprises Inc
NYSE:NUS
287.3m USD 0.2 -2 3.8 8.9
FR
L'Oreal SA
PAR:OR
199.9B EUR 4.6 31.2 19.2 23.3
UK
Unilever PLC
LSE:ULVR
116.1B GBP 2.2 23.7 146.6 169.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.7 51.5 36.1 39.7
UK
HALEON PLC
LSE:HLN
34.2B GBP 3 23.7 14.1 15.9
DE
Beiersdorf AG
XETRA:BEI
26.8B EUR 2.7 29.3 12.4 15.1
US
Estee Lauder Companies Inc
NYSE:EL
21.4B USD 1.4 -30.5 11.3 17.6
JP
Kao Corp
TSE:4452
2.8T JPY 1.7 26.1 11.2 18
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9.2 -286.1 42.2 45.3
CN
Giant Biogene Holding Co Ltd
HKEX:2367
79.3B HKD 13.4 36.1 27.9 28.4
IN
Dabur India Ltd
NSE:DABUR
858.9B INR 6.8 47.8 35.8 43.7
P/E Multiple
Earnings Growth PEG
US
NU Skin Enterprises Inc
NYSE:NUS
Average P/E: 33.7
Negative Multiple: -2 		N/A N/A
FR
L'Oreal SA
PAR:OR
31.2
9%
3.5
UK
Unilever PLC
LSE:ULVR
23.7
14%
1.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51.5
9%
5.7
UK
HALEON PLC
LSE:HLN
23.7
13%
1.8
DE
Beiersdorf AG
XETRA:BEI
29.3
12%
2.4
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -30.5
43%
N/A
JP
Kao Corp
TSE:4452
26.1
10%
2.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -286.1 N/A N/A
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
36.1
25%
1.4
IN
Dabur India Ltd
NSE:DABUR
47.8
9%
5.3

See Also

Summary
NUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NUS stock valuation using valuation multiples.
Wall Street Estimates
NUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.